CONTEXT: It has been proposed that adiposity is a protective response to excess caloric supply, but it is cardiometabolically harmful once adipocytes become inflamed. OBJECTIVE: The objective of the study was to assess whether elevated C-reactive protein (CRP), a measure of systemic inflammation, can differentiate individuals at higher mortality risk due to excess adiposity. DESIGN, SETTING, AND PARTICIPANTS: We conducted an observational study of 16,486 white and 11,168 black men and women in the Reasons for Geographic and Racial Differences in Stroke study, a U.S. national cohort. MAIN OUTCOME: The main outcome was all-cause mortality. RESULTS: The mean age of the cohort was 64 ± 9 yr. Over a 6-yr period, 927 whites and 669 blacks died. The absolute risk of death was highest among underweight whites and blacks (9.2 and 14%, respectively), not the obese (4.7% whites; 4.0% blacks) or severely obese (5.9% whites; and 4.6% blacks). Among those with elevated CRP (≥3 vs. <1 mg/liter), underweight [hazard ratio (HR) 2.08, 95% confidence interval (CI) 1.03-4.21] and normal-weight (HR 2.62, 95% CI 1.87-3.67) whites were at significantly higher mortality risk but not severely obese whites (HR 1.55, 95% CI 0.77-2.96), resulting in a statistical interaction (P = 0.01). Similar results were also seen for blacks, although a higher mortality risk among severely obese blacks with CRP 3 or greater vs. less than 1 mg/liter was also demonstrated (HR 2.58, 95% CI 1.04-6.41). Among whites and black women, higher waist circumference was associated with an increased mortality risk, although this relationship was not modified by CRP levels (P = 0.47 for whites and P = 0.25 for blacks). CONCLUSION: Among middle-aged and older adults, the addition of CRP was most informative among underweight and normal-weight individuals, not the obese. This negated our hypothesis that increased levels of CRP would differentiate individuals at higher mortality risk due to excess adiposity.
CONTEXT: It has been proposed that adiposity is a protective response to excess caloric supply, but it is cardiometabolically harmful once adipocytes become inflamed. OBJECTIVE: The objective of the study was to assess whether elevated C-reactive protein (CRP), a measure of systemic inflammation, can differentiate individuals at higher mortality risk due to excess adiposity. DESIGN, SETTING, AND PARTICIPANTS: We conducted an observational study of 16,486 white and 11,168 black men and women in the Reasons for Geographic and Racial Differences in Stroke study, a U.S. national cohort. MAIN OUTCOME: The main outcome was all-cause mortality. RESULTS: The mean age of the cohort was 64 ± 9 yr. Over a 6-yr period, 927 whites and 669 blacks died. The absolute risk of death was highest among underweight whites and blacks (9.2 and 14%, respectively), not the obese (4.7% whites; 4.0% blacks) or severely obese (5.9% whites; and 4.6% blacks). Among those with elevated CRP (≥3 vs. <1 mg/liter), underweight [hazard ratio (HR) 2.08, 95% confidence interval (CI) 1.03-4.21] and normal-weight (HR 2.62, 95% CI 1.87-3.67) whites were at significantly higher mortality risk but not severely obese whites (HR 1.55, 95% CI 0.77-2.96), resulting in a statistical interaction (P = 0.01). Similar results were also seen for blacks, although a higher mortality risk among severely obese blacks with CRP 3 or greater vs. less than 1 mg/liter was also demonstrated (HR 2.58, 95% CI 1.04-6.41). Among whites and black women, higher waist circumference was associated with an increased mortality risk, although this relationship was not modified by CRP levels (P = 0.47 for whites and P = 0.25 for blacks). CONCLUSION: Among middle-aged and older adults, the addition of CRP was most informative among underweight and normal-weight individuals, not the obese. This negated our hypothesis that increased levels of CRP would differentiate individuals at higher mortality risk due to excess adiposity.
Authors: Beatriz Cepeda-Valery; Gregg S Pressman; Vincent M Figueredo; Abel Romero-Corral Journal: Nat Rev Cardiol Date: 2011-01-25 Impact factor: 32.419
Authors: Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard Journal: Neuroepidemiology Date: 2005-06-29 Impact factor: 3.282
Authors: Samuel Klein; Lora E Burke; George A Bray; Steven Blair; David B Allison; Xavier Pi-Sunyer; Yuling Hong; Robert H Eckel Journal: Circulation Date: 2004-10-27 Impact factor: 29.690
Authors: Susan G Lakoski; Mary Cushman; Michael Criqui; Tatjana Rundek; Roger S Blumenthal; Ralph B D'Agostino; David M Herrington Journal: Am Heart J Date: 2006-09 Impact factor: 4.749
Authors: Mary Cushman; Alice M Arnold; Bruce M Psaty; Teri A Manolio; Lewis H Kuller; Gregory L Burke; Joseph F Polak; Russell P Tracy Journal: Circulation Date: 2005-06-27 Impact factor: 29.690
Authors: Peter Penson; D Leann Long; George Howard; Virginia J Howard; Steven R Jones; Seth S Martin; Dimitri P Mikhailidis; Paul Muntner; Manfredi Rizzo; Daniel J Rader; Monika M Safford; Amirhossein Sahebkar; Peter P Toth; Maciej Banach Journal: Cardiovasc Res Date: 2019-01-01 Impact factor: 10.787
Authors: Jennifer W Bea; Cynthia A Thomson; Betsy C Wertheim; J Skye Nicholas; Kacey C Ernst; Chengcheng Hu; Rebecca D Jackson; Jane A Cauley; Cora E Lewis; Bette Caan; Denise J Roe; Zhao Chen Journal: Am J Epidemiol Date: 2015-09-07 Impact factor: 4.897
Authors: Inna Lisko; Kristina Tiainen; Sari Stenholm; Tiina Luukkaala; Mikko Hurme; Terho Lehtimäki; Antti Hervonen; Marja Jylhä Journal: Rejuvenation Res Date: 2012-09-21 Impact factor: 4.663
Authors: Peter E Penson; D Leann Long; George Howard; Peter P Toth; Paul Muntner; Virginia J Howard; Monica M Safford; Steven R Jones; Seth S Martin; Mohsen Mazidi; Alberico L Catapano; Maciej Banach Journal: Eur Heart J Date: 2018-10-21 Impact factor: 29.983